Evidence map›Paper›PMID 33464320›Full record

ArticleJAMA network open2021

Genetics of Smoking and Risk of Atherosclerotic Cardiovascular Diseases: A Mendelian Randomization Study.

Michael G Levin, Derek Klarin, Themistocles L Assimes, Matthew S Freiberg, Erik Ingelsson, Julie Lynch, Pradeep Natarajan, Christopher O'Donnell, Daniel J Rader, Philip S Tsao and 4 more

Open access · goldAbstract read
In one paragraph

Article in JAMA network open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 4 pooled it
9.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 4 syntheses or guidelines pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 10 institutions in 1 country.

Michael G LevinDivision of Cardiovascular Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia.
Derek KlarinMalcolm Randall VA Medical Center, Gainesville, Florida.
Themistocles L AssimesPalo Alto VA Healthcare System, Palo Alto, California.
Matthew S FreibergDivision of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Erik IngelssonDivision of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California.
Julie LynchEdith Nourse VA Medical Center, Bedford, Massachusetts.
Pradeep NatarajanCardiovascular Research Center, Massachusetts General Hospital, Boston.
Christopher O'DonnellVA Boston Healthcare System, Boston, Massachusetts.
Daniel J RaderDepartment of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia.
Philip S TsaoPalo Alto VA Healthcare System, Palo Alto, California.
Kyong-Mi ChangDepartment of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia.
Benjamin F VoightCorporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania.
Scott M DamrauerCorporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania.
VA Million Veteran Program
Cardiovascular Institute of the South · USPhiladelphia VA Medical Center · USTranslational Therapeutics (United States) · USBroad Institute · USEdith Nourse Rogers Memorial Veterans Hospital · USGeriatric Research Education and Clinical Center · USUniversity of Florida · USUniversity of Pennsylvania · USVA Boston Healthcare System · USVA Palo Alto Health Care System · US

Funding

Tennessee CFAR: Implementation of Culturally Responsive Trauma-Informed Care with Youth with HIV in Memphis, TNP30AI110527 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Spyros A Kalams · 2015 to 2026
$27.5M
Algorithms to identify non-coding mutational burden and disease-relevant pathwaysR56DK101478 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI VOIGHT, BENJAMIN FRANKLIN · 2019 to 2019
$272k
Precision Cardio-Metabolic Phenotyping for Genetic Discovery and Risk PredictionIK2CX001780 · VA · PHILADELPHIA VA MEDICAL CENTER · PI DAMRAUER, SCOTT MICHAEL · 2018 to 2023
–
CSRD VA IK2 CX001780Medical Research Council MC_PC_17228Medical Research Council MC_QA137853NIAID NIH HHS P30 AI110527NIDDK NIH HHS R56 DK101478
6 · The paper itself

Abstract

Importance: Smoking is associated with atherosclerotic cardiovascular disease, but the relative contribution to each subtype (coronary artery disease [CAD], peripheral artery disease [PAD], and large-artery stroke) remains less well understood. Objective: To determine the association between genetic liability to smoking and risk of CAD, PAD, and large-artery stroke. Design, Setting, and Participants: Mendelian randomization study using summary statistics from genome-wide associations of smoking (UK Biobank; up to 462 690 individuals), CAD (Coronary Artery Disease Genome Wide Replication and Meta-analysis plus the Coronary Artery Disease Genetics Consortium; up to 60 801 cases, 123 504 controls), PAD (VA Million Veteran Program; up to 24 009 cases, 150 983 controls), and large-artery stroke (MEGASTROKE; up to 4373 cases, 406 111 controls). This study was conducted using summary statistic data from large, previously described cohorts. Review of those publications does not reveal the total recruitment dates for those cohorts. Data analyses were conducted from August 2019 to June 2020. Exposures: Genetic liability to smoking (as proxied by genetic variants associated with lifetime smoking index). Main Outcomes and Measures: Risk (odds ratios [ORs]) of CAD, PAD, and large-artery stroke. Results: Genetic liability to smoking was associated with increased risk of PAD (OR, 2.13; 95% CI, 1.78-2.56; P = 3.6 × 10-16), CAD (OR, 1.48; 95% CI, 1.25-1.75; P = 4.4 × 10-6), and stroke (OR, 1.40; 95% CI, 1.02-1.92; P = .04). Genetic liability to smoking was associated with greater risk of PAD than risk of large-artery stroke (ratio of ORs, 1.52; 95% CI, 1.05-2.19; P = .02) or CAD (ratio of ORs, 1.44; 95% CI, 1.12-1.84; P = .004). The association between genetic liability to smoking and atherosclerotic cardiovascular diseases remained independent from the effects of smoking on traditional cardiovascular risk factors. Conclusions and Relevance: In this mendelian randomization analysis of data from large studies of atherosclerotic cardiovascular diseases, genetic liability to smoking was a strong risk factor for CAD, PAD, and stroke, although the estimated association was strongest between smoking and PAD. The association between smoking and atherosclerotic cardiovascular disease was independent of traditional cardiovascular risk factors.

Indexed as

Mendelian Randomization AnalysisSmokingAtherosclerosisCardiovascular DiseasesFemaleGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansMalePeripheral Vascular DiseasesRisk FactorsStroke

Identifiers

PMID33464320
PMCPMC7816104
OpenAlexW3123326550

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.